Cover Image
市場調查報告書

Ampio Pharmaceuticals, Inc. - 產品平台分析

Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226242
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Ampio Pharmaceuticals, Inc. - 產品平台分析 Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月23日 內容資訊: 英文 32 Pages
簡介

Ampio Pharmaceuticals, Inc.是專門發明及開發治療法選擇有限的發炎疾病治療法之生物製藥公司。特別著重於眼科疾病,性功能障礙,腎臟病,代謝性疾病,中樞神經系統疾病等治療藥及診斷藥的開發。

本報告提供BioCryst Pharmaceuticals, Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Ampio Pharmaceuticals, Inc.的基本資料

Ampio Pharmaceuticals, Inc.概要

  • 主要資訊
  • 企業資料

Ampio Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Ampio Pharmaceuticals, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Ampio Pharmaceuticals, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Ampio Pharmaceuticals, Inc.:藥物簡介

  • Ampion
  • danazol
  • NCE-001

Ampio Pharmaceuticals, Inc.:開發平台分析

Ampio Pharmaceuticals, Inc.

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ampio Pharmaceuticals, Inc.:最近的開發平台趨勢

Ampio Pharmaceuticals, Inc.:暫停中的計劃

Ampio Pharmaceuticals, Inc.:企業發表

Ampio Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07596CDB

Summary

Global Markets Direct's, 'Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Ampio Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ampio Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ampio Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ampio Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ampio Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Ampio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ampio Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ampio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ampio Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ampio Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ampio Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ampio Pharmaceuticals, Inc. Snapshot
    • Ampio Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Ampio Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Ampio Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Ampio Pharmaceuticals, Inc. - Pipeline Products Glance
    • Ampio Pharmaceuticals, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Ampio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Ampio Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Ampio Pharmaceuticals, Inc. - Drug Profiles
    • Ampion
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • danazol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NCE-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ampio Pharmaceuticals, Inc. - Pipeline Analysis
    • Ampio Pharmaceuticals, Inc. - Pipeline Products by Target
    • Ampio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Ampio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Ampio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Ampio Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Ampio Pharmaceuticals, Inc. - Dormant Projects
  • Ampio Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ampio Pharmaceuticals, Inc., Key Information
  • Ampio Pharmaceuticals, Inc., Key Facts
  • Ampio Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ampio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ampio Pharmaceuticals, Inc. - Phase III, 2015
  • Ampio Pharmaceuticals, Inc. - Phase I, 2015
  • Ampio Pharmaceuticals, Inc. - Preclinical, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Ampio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Ampio Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
  • Ampio Pharmaceuticals, Inc., Subsidiaries

List of Figures

  • Ampio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ampio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Ampio Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top